【导读】用于信使核糖核酸（mRNA）递送的脂质纳米颗粒（LNPs）已取得显著进展，但脂质纳米颗粒介导的脱氧核糖核酸（DNA）递送在临床上仍面临诸多挑战。1月13日，美国贝勒医学院研究人员在期刊《Molecular Cancer》上发表了研究论文，题为 ...

2024年10月8日，杜克大学Nicholas S Heaton携手mRNA诺奖得主Drew Weissman在《Nature Communications》杂志上发表题为“Improved influenza vaccine responses ...

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in ...

PRX是维肽瀛联合日本熊本大学的一款针对核酸药物递送的纳米分子。该分子不仅展现出极其稳定的递送效率，并可实现多器官精准靶向，与其他同类技术相比，生产工艺简单、安全性高，具有更具前景的应用空间。目前该分子已验证了多种核酸类型的递送验证，结果令人鼓舞。

PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.

NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential for ...

A Dx&Vx representative stated, "The ultimate goal of the Ferritin platform-based VLP vaccine under development is to provide a safe, superior, and convenient vaccine that offers maximum protection ...